APA (7th ed.) Citation

Zhu, M., Han, Y., Gu, T., Wang, R., Si, X., Kong, D., . . . Qian, P. (2024). Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway. Cell reports (Cambridge), 43(4), 114065. https://doi.org/10.1016/j.celrep.2024.114065

Chicago Style (17th ed.) Citation

Zhu, Meng, et al. "Class I HDAC Inhibitors Enhance Antitumor Efficacy and Persistence of CAR-T Cells by Activation of the Wnt Pathway." Cell Reports (Cambridge) 43, no. 4 (2024): 114065. https://doi.org/10.1016/j.celrep.2024.114065.

MLA (9th ed.) Citation

Zhu, Meng, et al. "Class I HDAC Inhibitors Enhance Antitumor Efficacy and Persistence of CAR-T Cells by Activation of the Wnt Pathway." Cell Reports (Cambridge), vol. 43, no. 4, 2024, p. 114065, https://doi.org/10.1016/j.celrep.2024.114065.